What is the ED95 dose of Prilocaine for femoral nerve block using ultrasound?” - MED and femoral nerve block
Phase 1
- Registration Number
- EUCTR2008-008177-57-GB
- Lead Sponsor
- niversity of Leeds
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
•ASA 1-3 patients
•Age > 18 years
•Routine patients presenting for muscle biopsy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
•ASA > 3
•Age < 18 years
•Allergy to prilocaine
•Unable to give informed consent
•Body Mass Index > 35
•Patients on sulphonamides, antimalarials
•Pregnant woman
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To find out the ED95 of 1% prilocaine for femoral nerve block using ultrasound.;Secondary Objective: -;Primary end point(s): Assessment of effect of block to cold with an alcohol swab at the motor point of vastus medialis after femoral nerve block. The motor point of vastus medialis will be identified using a nerve stimulator after the femoral nerve block and is usually about 5 cm medial and cephalad to the knee cap. This does not hurt.
- Secondary Outcome Measures
Name Time Method